These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 31445162)
21. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754 [TBL] [Abstract][Full Text] [Related]
22. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease. Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614 [TBL] [Abstract][Full Text] [Related]
23. Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice. Helwig M; Klinkenberg M; Rusconi R; Musgrove RE; Majbour NK; El-Agnaf OM; Ulusoy A; Di Monte DA Brain; 2016 Mar; 139(Pt 3):856-70. PubMed ID: 26719384 [TBL] [Abstract][Full Text] [Related]
24. Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein. Frieg B; Geraets JA; Strohäker T; Dienemann C; Mavroeidi P; Jung BC; Kim WS; Lee SJ; Xilouri M; Zweckstetter M; Schröder GF Commun Biol; 2022 Sep; 5(1):1040. PubMed ID: 36180728 [TBL] [Abstract][Full Text] [Related]
25. α-Synuclein Propagation Mouse Models of Parkinson's Disease. Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198 [TBL] [Abstract][Full Text] [Related]
26. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies. Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760 [TBL] [Abstract][Full Text] [Related]
27. Progression of phosphorylated α-synuclein in Macaca fuscata. Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430 [TBL] [Abstract][Full Text] [Related]
28. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
30. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Holmqvist S; Chutna O; Bousset L; Aldrin-Kirk P; Li W; Björklund T; Wang ZY; Roybon L; Melki R; Li JY Acta Neuropathol; 2014 Dec; 128(6):805-20. PubMed ID: 25296989 [TBL] [Abstract][Full Text] [Related]
31. Conformation-specific Antibodies Targeting Aggregated Forms of α-synuclein Block the Propagation of Synucleinopathy. Choi M; Kim TK; Ahn J; Lee JS; Jung BC; An S; Kim D; Lee MJ; Mook-Jung I; Lee SH; Lee SJ Exp Neurobiol; 2022 Feb; 31(1):29-41. PubMed ID: 35256542 [TBL] [Abstract][Full Text] [Related]
32. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death. Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444 [TBL] [Abstract][Full Text] [Related]
33. Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson's disease. Yan M; Xiong M; Dai L; Zhang X; Zha Y; Deng X; Yu Z; Zhang Z NPJ Parkinsons Dis; 2022 Jan; 8(1):1. PubMed ID: 35013321 [TBL] [Abstract][Full Text] [Related]
34. Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors. Gustafsson G; Eriksson F; Möller C; da Fonseca TL; Outeiro TF; Lannfelt L; Bergström J; Ingelsson M Cell Mol Neurobiol; 2017 Jan; 37(1):121-131. PubMed ID: 26961542 [TBL] [Abstract][Full Text] [Related]
35. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824 [TBL] [Abstract][Full Text] [Related]
37. Immunotherapies for Parkinson's Disease: Progression of Clinical Development. Teng JS; Ooi YY; Chye SM; Ling APK; Koh RY CNS Neurol Disord Drug Targets; 2021; 20(9):802-813. PubMed ID: 34042040 [TBL] [Abstract][Full Text] [Related]
38. Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease. Yan M; Meng L; Dai L; Zhang X; Chen G; Zheng Y; Zha Y; Zeng Y; Zhang Z Biochem Biophys Res Commun; 2020 Sep; 529(4):1053-1060. PubMed ID: 32819564 [TBL] [Abstract][Full Text] [Related]
39. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Orimo S Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627 [TBL] [Abstract][Full Text] [Related]
40. Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight. Upcott M; Chaprov KD; Buchman VL Molecules; 2021 Dec; 26(23):. PubMed ID: 34885933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]